- About UsOur Story, Our Team & Support Information
- What We DoAdvocacy to Achieve the End of AIDS
- Advocate for Policies and Actions
- Build Rapid-Response Networks
- Advocacy Fellows Program
- PxROAR (Research, Outreach, Advocacy and Representation)
- Women's HIV Prevention Tracking Project (WHiPT)
- Advocacy Partners Forum
- Improve Research Conduct
- Provide Tools for Decision-Making
- Translate & Share the Latest Information
- Our FocusInterventions to End the Epidemic
- Combination Prevention
- Male and Female Condoms
- Hormonal Contraceptives and HIV
- Multipurpose Prevention Technologies
- HIV Vaccine
- Voluntary Medical Male Circumcision
- How Research Happens
- ResourcesPublications, Infographics, Events & More
- MediaInformation & Resources for the Press
- Our BlogPrevention News & Perspective
There is momentum and promise in the search for an HIV vaccine.
An effective preventive HIV vaccine would teach the body how to prevent HIV infection. Vaccines are the most powerful public health tools available—and an HIV vaccine would play a powerful role in ensuring the end to the AIDS epidemic.
While effective vaccines remain years away, there are more reasons for hope than ever before. Researchers are expanding on the result of a 2009 trial that showed, for the first time, that a vaccine can reduce the risk of HIV infection. They’re also pursuing groundbreaking research with other novel vaccine strategies, including broadly neutralizing antibodies that target a wide range of HIV strains. At the same time, there is also exciting work in efforts to understand if and how to cure HIV in people who are already infected. The timeline for this work is long and uncertain. Here, too, advocacy is needed to sustain momentum.
Today’s momentum depends on sustained funding. Policy makers and funders around the world must have the courage to sustain vital HIV vaccine research for years to come, and advocates must keep the pressure on them to maintain their commitments.
What We're Reading